ASH 2014: Rough Notes from Dr. Clive Zent and ... - CLL Support

CLL Support

22,513 members38,667 posts

ASH 2014: Rough Notes from Dr. Clive Zent and Dr. Wiestner on Prognostic Factors and Resistance in CLL

bkoffman profile image
bkoffmanCLL CURE Hero
2 Replies

Hi friends,

I have just posted on my blog: bkoffman.blogspot.com my rough notes from a lecture on CLL from ASH 2014. I hope it offers two things.

First it contains a flood of information on how our understanding of prognostic indicators, tumor heterogeneity, and clonal evolution is changing.

Second, it gives you a glance under the hood of what goes on at these meetings.

The CLL Society's website is coming very soon. Tons of new educational and supportive material and helpful links.

It has been a ton of work, and I so hope it helps meet some of the unmet needs of our community.

Stay strong

We are all in this together

Brian

bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
AussieNeil profile image
AussieNeilAdministrator

Thanks Brian. Yes it is rather like drinking from a fire hose! The comment from Dr. Clive Zent's presentation "Clonal Evolution: No longer believe we develop new clones but start with small one that grow." caught my eye. After all this time are you able to expand on what was meant by that?

Neil

bkoffman profile image
bkoffmanCLL CURE Hero in reply to AussieNeil

Very small, sometimes too small to find, sub clones probably grow at different rates, especially but not exclusively in response to therapy. Not everyone agrees, but it is looking more likely.

You may also like...

ASH 2014. Dr. Sharman discusses the biology of our CLL cells

together Brian Koffman Volunteer Medical Director of the CLL Society http://cllsociety.org...

My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.

ating-cll/ Enjoying a total of two weeks at home before I head to Bethesda for our educational forum

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

Saturday I will be in Minneapolis for the CLL Society/Mayo Educational Forum, so if you are...

CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO

fantastic ASH, but still have news to share from ASCO. But first here is a link to our poster on...

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

my blog: http://bkoffman.blogspot.com Stay strong. We are all in this together. Brian...